XML 26 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Retained earnings
Accumulated other comprehensive income (loss)
Treasury Stock, Common
Balances at January 1, 2018 at Dec. 31, 2020 $ 2,282,070 $ 1,638,947 $ 720,429 $ 48,664 $ (125,970)
Balances at January 1, 2018 at Dec. 31, 2020   104,281,794     (6,259,865)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 205,160   205,160    
Other comprehensive loss (49,097)     (49,097)  
Cash dividends declared:          
Common Stock at $0.92 per share in 2021, $0.92 per share in 2022, and $0.92 per share in 2023 (88,116)   (88,116)    
Stock Issued During Period, Shares, Acquisitions         405,805
Common stock issued in connection with business combinations $ 10,000 $ 1,251     $ 8,749
Treasury Stock, Shares, Acquired (4,633,355)       (4,633,355)
Treasury Stock, Value, Acquired, Cost Method $ (108,077)       $ (108,077)
Exercise of stock options, net of shares purchased (in shares)         6,936
Exercise of stock options, net of shares purchased (64) (81)     $ (145)
Restricted stock awards, net of forfeitures (in shares)         347,925
Restricted stock awards, net of forfeitures (2,697) (9,394)     $ 6,697
Share-based compensation expense 9,635 $ 9,635      
Ending Balances (in shares) at Dec. 31, 2021   104,281,794     (10,132,554)
Ending Balances at Dec. 31, 2021 2,258,942 $ 1,640,358 837,473 (433) $ (218,456)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 217,612   217,612    
Other comprehensive loss (358,230)     (358,230)  
Cash dividends declared:          
Common Stock at $0.92 per share in 2021, $0.92 per share in 2022, and $0.92 per share in 2023 (86,848)   (86,848)    
Common stock issued in connection with business combinations 0        
Exercise of stock options, net of shares purchased (in shares)         15,660
Exercise of stock options, net of shares purchased (177) (160)     $ (337)
Restricted stock awards, net of forfeitures (in shares)         726,199
Restricted stock awards, net of forfeitures (3,659) (18,972)     $ 15,313
Share-based compensation expense 13,379 $ 13,379      
Ending Balances (in shares) at Dec. 31, 2022   104,281,794     (9,390,695)
Ending Balances at Dec. 31, 2022 2,041,373 $ 1,634,605 968,237 (358,663) $ (202,806)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 255,863   255,863    
Other comprehensive loss 48,844     48,844  
Cash dividends declared:          
Common Stock at $0.92 per share in 2021, $0.92 per share in 2022, and $0.92 per share in 2023 (87,382)   (87,382)    
Common stock issued in connection with business combinations $ 0        
Exercise of stock options, net of shares purchased (in shares) 4,855       4,855
Exercise of stock options, net of shares purchased $ (48) (57)     $ (105)
Restricted stock awards, net of forfeitures (in shares)         245,290
Restricted stock awards, net of forfeitures (5,670) (10,474)     $ 4,804
Share-based compensation expense 14,898 $ 14,898      
Ending Balances (in shares) at Dec. 31, 2023   104,281,794     (9,140,550)
Ending Balances at Dec. 31, 2023 $ 2,267,974 $ 1,638,972 $ 1,136,718 $ (309,819) $ (197,897)